191 related articles for article (PubMed ID: 19681667)
41. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
42. Sustained release of isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment.
Zhang L; Li Y; Zhang Y; Zhu C
Sci China Life Sci; 2016 Jul; 59(7):724-31. PubMed ID: 27278371
[TBL] [Abstract][Full Text] [Related]
43. The effect of nanoparticles on gastrointestinal release from modified κ-carrageenan nanocomposite hydrogels.
Hezaveh H; Muhamad II
Carbohydr Polym; 2012 Jun; 89(1):138-45. PubMed ID: 24750615
[TBL] [Abstract][Full Text] [Related]
44. Structural relaxation and glass transition in high-solid gelatin systems crosslinked with genipin.
Whitehead FA; Young SA; Kasapis S
Int J Biol Macromol; 2019 Dec; 141():867-875. PubMed ID: 31499108
[TBL] [Abstract][Full Text] [Related]
45. [Comparison of characteristics between glutaraldehyde- and genipin-crosslinked gelatin microspheres].
Li M; Liu X; Liu X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):87-91. PubMed ID: 19192887
[TBL] [Abstract][Full Text] [Related]
46. Modulation of stability and mucoadhesive properties of chitosan microspheres for therapeutic gastric application.
Fernandes M; Gonçalves IC; Nardecchia S; Amaral IF; Barbosa MA; Martins MC
Int J Pharm; 2013 Sep; 454(1):116-24. PubMed ID: 23850814
[TBL] [Abstract][Full Text] [Related]
47. Macrophage-specific targeting of isoniazid through mannosylated gelatin microspheres.
Tiwari S; Chaturvedi AP; Tripathi YB; Mishra B
AAPS PharmSciTech; 2011 Sep; 12(3):900-8. PubMed ID: 21732158
[TBL] [Abstract][Full Text] [Related]
48. Impact of metal oxide nanoparticles on oral release properties of pH-sensitive hydrogel nanocomposites.
Hezaveh H; Muhamad II
Int J Biol Macromol; 2012 Jun; 50(5):1334-40. PubMed ID: 22484730
[TBL] [Abstract][Full Text] [Related]
49. Comparative analysis of gelatin scaffolds crosslinked by genipin and silane coupling agent.
Tonda-Turo C; Gentile P; Saracino S; Chiono V; Nandagiri VK; Muzio G; Canuto RA; Ciardelli G
Int J Biol Macromol; 2011 Nov; 49(4):700-6. PubMed ID: 21767562
[TBL] [Abstract][Full Text] [Related]
50. Novel interpenetrating network microspheres of xanthan gum-poly(vinyl alcohol) for the delivery of diclofenac sodium to the intestine--in vitro and in vivo evaluation.
Ray S; Banerjee S; Maiti S; Laha B; Barik S; Sa B; Bhattacharyya UK
Drug Deliv; 2010; 17(7):508-19. PubMed ID: 20482471
[TBL] [Abstract][Full Text] [Related]
51. Incorporation of antitubercular drug isoniazid in pharmaceutically accepted microemulsion: effect on microstructure and physical parameters.
Mehta SK; Kaur G; Bhasin KK
Pharm Res; 2008 Jan; 25(1):227-36. PubMed ID: 17577642
[TBL] [Abstract][Full Text] [Related]
52. Self-assembled gelatin-ι-carrageenan encapsulation structures for intestinal-targeted release applications.
Gómez-Mascaraque LG; Llavata-Cabrero B; Martínez-Sanz M; Fabra MJ; López-Rubio A
J Colloid Interface Sci; 2018 May; 517():113-123. PubMed ID: 29421671
[TBL] [Abstract][Full Text] [Related]
53. Interpenetrating polymer network of locust bean gum-poly (vinyl alcohol) for controlled release drug delivery.
Kaity S; Isaac J; Ghosh A
Carbohydr Polym; 2013 Apr; 94(1):456-67. PubMed ID: 23544563
[TBL] [Abstract][Full Text] [Related]
54. Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.
Patil SB; Sawant KK
J Microencapsul; 2009 Aug; 26(5):432-43. PubMed ID: 18932060
[TBL] [Abstract][Full Text] [Related]
55. Chitosan-genipin microspheres for the controlled release of drugs: clarithromycin, tramadol and heparin.
Harris R; Lecumberri E; Heras A
Mar Drugs; 2010 May; 8(6):1750-62. PubMed ID: 20631867
[TBL] [Abstract][Full Text] [Related]
56. Preparation and in vitro evaluation of xanthan gum facilitated superabsorbent polymeric microspheres.
Bhattacharya SS; Mazahir F; Banerjee S; Verma A; Ghosh A
Carbohydr Polym; 2013 Oct; 98(1):64-72. PubMed ID: 23987317
[TBL] [Abstract][Full Text] [Related]
57. Tailoring of alginate-gelatin microspheres properties for oral Ciprofloxacin-controlled release against Pseudomonas aeruginosa.
Islan GA; Castro GR
Drug Deliv; 2014 Dec; 21(8):615-26. PubMed ID: 24401147
[TBL] [Abstract][Full Text] [Related]
58. Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium.
Wei HJ; Yang HH; Chen CH; Lin WW; Chen SC; Lai PH; Chang Y; Sung HW
J Control Release; 2007 Jul; 120(1-2):27-34. PubMed ID: 17532519
[TBL] [Abstract][Full Text] [Related]
59. BCP ceramic microspheres as drug delivery carriers: synthesis, characterisation and doxycycline release.
Victor SP; Kumar TS
J Mater Sci Mater Med; 2008 Jan; 19(1):283-90. PubMed ID: 17597367
[TBL] [Abstract][Full Text] [Related]
60. Effect of process variables on particle size and viability of Bifidobacterium lactis Bb-12 in genipin-gelatin microspheres.
Annan NT; Borza A; Moreau DL; Allan-Wojtas PM; Hansen LT
J Microencapsul; 2007 Mar; 24(2):152-62. PubMed ID: 17454426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]